ZFIN ID: ZDB-EXP-140410-19
Experiment Conditions Description: physical alteration: anatomical structure, chemical treatment: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
physical alteration: anatomical structure
Name: physical alteration
Synonyms:
Definition: Experimental condition in which an anatomical structure, cell, or organ has sustained targeted physical change, usually through the use of an instrument.
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000229]
Name: anatomical structure
Synonyms: anatomical structures
Definition: Zebrafish anatomical entity that has inherent 3D shape and is generated by coordinated expression of the organism's own genome.
Ontology: Anatomy Ontology [ZFA:0000037]
chemical treatment: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
Name: chemical treatment
Synonyms:
Definition: Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption.
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000111]
Name: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
Synonyms: ABL inhibitor, ABL inhibitors, ABL1 inhibitor, ABL1 inhibitors, ABL2 inhibitor, ABL2 inhibitors, ABLL inhibitor, ABLL inhibitors, ACK1 inhibitor, ACK1 inhibitors, ACK2 inhibitor, ACK2 inhibitors, AGMX1 inhibitor, AGMX1 inhibitors, ARG inhibitor, ARG inhibitors, ATK inhibitor, ATK inhibitors, ATP:[protein]-L-tyrosine O-phosphotransferase (non-specific) inhibitor, ATP:[protein]-L-tyrosine O-phosphotransferase (non-specific) inhibitors, BLK inhibitor, BLK inhibitors, Bmk inhibitor, Bmk inhibitors, BMX inhibitor, BMX inhibitors, BRK inhibitor, BRK inhibitors, Bruton's tyrosine kinase inhibitor, Bruton's tyrosine kinase inhibitors, Bsk inhibitor, Bsk inhibitors, BTK inhibitor, BTK inhibitors, BTKL inhibitor, BTKL inhibitors, CAKb inhibitor, CAKb inhibitors, Cdgip inhibitor, Cdgip inhibitors, CHK inhibitor, CHK inhibitors, CSK inhibitor, CSK inhibitors, CTK inhibitor, CTK inhibitors, CYL inhibitor, CYL inhibitors, cytoplasmic protein tyrosine kinase inhibitor, cytoplasmic protein tyrosine kinase inhibitors, EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitors, EC 2.7.10.2 inhibitor, EC 2.7.10.2 inhibitors, EMT inhibitor, EMT inhibitors, ETK inhibitor, ETK inhibitors, Fadk inhibitor, Fadk inhibitors, FAK inhibitor, FAK inhibitors, FAK2 inhibitor, FAK2 inhibitors, FER inhibitor, FER inhibitors, Fert1/2 inhibitor, Fert1/2 inhibitors, FES inhibitor, FES inhibitors, FGR inhibitor, FGR inhibitors, focal adhesion kinase inhibitor, focal adhesion kinase inhibitors, FPS inhibitor, FPS inhibitors, FRK inhibitor, FRK inhibitors, FYN inhibitor, FYN inhibitors, HCK inhibitor, HCK inhibitors, HCTK inhibitor, HCTK inhibitors, HYL inhibitor, HYL inhibitors, IMD1 inhibitor, IMD1 inhibitors, ITK inhibitor, ITK inhibitors, IYK inhibitor, IYK inhibitors, JAK1 inhibitor, JAK1 inhibitors, JAK2 inhibitor, JAK2 inhibitors, JAK3 inhibitor, JAK3 inhibitors, Janus kinase 1 inhibitor, Janus kinase 1 inhibitors, Janus kinase 2 inhibitor, Janus kinase 2 inhibitors, Janus kinase 3 inhibitor, Janus kinase 3 inhibitors, Janus kinase inhibitor, JTK1 inhibitor, JTK1 inhibitors, JTK9 inhibitor, JTK9 inhibitors, L-JAK inhibitor, L-JAK inhibitors, LCK inhibitor, LCK inhibitors, LSK inhibitor, LSK inhibitors, LYN inhibitor, LYN inhibitors, MATK inhibitor, MATK inhibitors, non-specific protein-tyrosine kinase (EC 2.7.10.2) inhibitor, non-specific protein-tyrosine kinase (EC 2.7.10.2) inhibitors, Ntk inhibitor, Ntk inhibitors, p60c-src protein tyrosine kinase inhibitor, p60c-src protein tyrosine kinase inhibitors, PKB inhibitor, PKB inhibitors, PSCTK inhibitor, PSCTK inhibitors, PSCTK1 inhibitor, PSCTK1 inhibitors, PSCTK2 inhibitor, PSCTK2 inhibitors, PSCTK4 inhibitor, PSCTK4 inhibitors, PSCTK5 inhibitor, PSCTK5 inhibitors, PTK2 inhibitor, PTK2 inhibitors, PTK2B inhibitor, PTK2B inhibitors, PTK6 inhibitor, PTK6 inhibitors, PYK2 inhibitor, PYK2 inhibitors, RAFTK inhibitor, RAFTK inhibitors, RAK inhibitor, RAK inhibitors, Rlk inhibitor, Rlk inhibitors, Sik inhibitor, Sik inhibitors, SLK inhibitor, SLK inhibitors, SRC inhibitor, SRC inhibitors, SRC2 inhibitor, SRC2 inhibitors, SRK inhibitor, SRK inhibitors, SRM inhibitor, SRM inhibitors, SRMS inhibitor, SRMS inhibitors, STD inhibitor, STD inhibitors, SYK inhibitor, SYK inhibitors, SYN inhibitor, SYN inhibitors, Tck inhibitor, Tck inhibitors, TEC inhibitor, TEC inhibitors, TNK1 inhibitor, TNK1 inhibitors, Tsk inhibitor, Tsk inhibitors, TXK inhibitor, TXK inhibitors, TYK2 inhibitor, TYK2 inhibitors, TYK3 inhibitor, TYK3 inhibitors, YES1 inhibitor, YES1 inhibitors, YK2 inhibitor, YK2 inhibitors, ZAP70 inhibitor, ZAP70 inhibitors
Definition: An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2).
Ontology: ChEBI [CHEBI:76617]  ( EBI )
Publication: Yoo et al., 2012
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.